Stay updated with breaking news from B lynne parshall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its price target boosted by Oppenheimer from $65.00 to $72.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has an outperform rating on the stock. A number of other research firms also recently weighed in on IONS. Royal Bank of Canada lifted their price target […] ....
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Rating of "Moderate Buy" by Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals (IONS) to Release Quarterly Earnings on Wednesday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals (NASDAQ:IONS) Downgraded by StockNews.com to "Sell" theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday. IONS has been the subject of a number of other reports. Needham & Company LLC reaffirmed a “buy” rating and set a […] ....